Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex-Reference-Cited by-同舟云学术

Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex

Published:2017-02 Issue:2 Volume:25 Page:463-471
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Howell Jessica J.,Hellberg Kristina,Turner Marc,Talbott George,Kolar Matthew J.,Ross Debbie S.,Hoxhaj Gerta,Saghatelian Alan,Shaw Reuben J.,Manning Brendan D.

Funder

Ellison Medical Foundation

NIH

George E. Hewitt Foundation for Medical Research

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference47 articles.

1. Regulation of mTORC1 by amino acids;Bar-Peled;Trends Cell Biol.,2014

2. Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1;Ben Sahra;Cancer Res.,2011

3. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling;Bolster;J. Biol. Chem.,2002

4. Are Metformin Doses Used in Murine Cancer Models Clinically Relevant?;Chandel;Cell Metab.,2016

5. Mammalian TOR: a homeostatic ATP sensor;Dennis;Science,2001

Cited by 316 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serial triphenylpropionic acid and N,N'-chelator mixed ligands Cu(II) complexes: Structure and biological properties;Journal of Molecular Structure;2025-02

2. Erythropoietin enhances iron bioavailability in HepG2 cells by downregulating hepcidin through mTOR, C/EBPα and HIF-1α;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-10

3. Adipocyte inflammation is the primary driver of hepatic insulin resistance in a human iPSC-based microphysiological system;Nature Communications;2024-09-12

4. Exploring the Mechanisms and Therapeutic Approaches of Mitochondrial Dysfunction in Alzheimer’s Disease: An Educational Literature Review;Molecular Neurobiology;2024-09-10

5. Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives;Critical Care;2024-09-03